Cargando…
Overview of approaches to estimate real-world disease progression in lung cancer
BACKGROUND: Randomized clinical trials of novel treatments for solid tumors normally measure disease progression using the Response Evaluation Criteria in Solid Tumors. However, novel, scalable approaches to estimate disease progression using real-world data are needed to advance cancer outcomes res...
Autores principales: | Amorrortu, Rossybelle, Garcia, Melany, Zhao, Yayi, El Naqa, Issam, Balagurunathan, Yoganand, Chen, Dung-Tsa, Thieu, Thanh, Schabath, Matthew B, Rollison, Dana E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637832/ https://www.ncbi.nlm.nih.gov/pubmed/37738580 http://dx.doi.org/10.1093/jncics/pkad074 |
Ejemplares similares
-
Demographic disparities in receipt of care at a comprehensive cancer center
por: Kirtane, Kedar, et al.
Publicado: (2023) -
Melanoma and CLL co-occurrence and survival: role of KC history
por: Zhao, Yayi, et al.
Publicado: (2023) -
Circulating Immunosuppressive Regulatory T Cells Predict Risk of Incident Cutaneous Squamous Cell Carcinoma
por: Rollison, Dana E., et al.
Publicado: (2021) -
Quantitative Imaging features Improve Discrimination of Malignancy in Pulmonary nodules
por: Balagurunathan, Yoganand, et al.
Publicado: (2019) -
Cutaneous viral infections associated with ultraviolet radiation exposure
por: Zhao, Yayi, et al.
Publicado: (2020)